About this course

  • Released: 5/26/2015
  • Expires: 5/26/2018

TRIPTAN-INDUCED DISRUPTION OF TRIGEMINO-CORTICAL CONNECTIVITY

LEARNING OBJECTIVES:

Upon completion of the article by Kröger et al, the participant should be able to:

  • State the action of triptans on 5-HT receptors
  • Discuss the findings from this study with regard to action of triptans on trigemino-cortical functional connectivity
  • Discuss how the findings from this study suggest why triptans have an effect on migraine but not nonmigraine pain

CORE COMPETENCIES:

The article by Kröger et al covers the following core competency:

  • Medical Knowledge
     

THE COST OF MULTIPLE SCLEROSIS DRUGS IN THE US AND THE PHARMACEUTICAL INDUSTRY: TOO BIG TO FAIL?

LEARNING OBJECTIVES:

Upon completion of the article by Hartung et al, the participant should be able to:

  • Recognize that the costs for disease-modifying therapies (DMTs) for multiple sclerosis (MS) have risen despite the availability of multiple treatment options
  • Discuss whether there is a relationship between the release of newer DMTs and the trend for cost for older DMTs
  • Compare DMT costs between the US and other countries
     

CORE COMPETENCIES:

The article by Hartung et al covers the following core competency:

  • Medical Knowledge
  • Systems Based Practice
     

AUTHOR DISCLOSURES:

Refer to listing above the references in each article.
 

THIS PAGE IS REQUIRED READING BEFORE BEGINNING ALL ACCME-ACCREDITED COURSES

ACCREDITATION STATEMENT

The American Academy of Neurology designates that participants will receive 1.5 AMA PRA Category 1 CME credits if both CME courses for the issue are completed. Physicians should only claim credit commensurate with the extent of their participation in the activity. The American Academy of Neurology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

MISSION STATEMENT/PROGRAM OBJECTIVES

After evaluating a specific article published in Neurology, participants in the CME activity should be able to demonstrate an increase in, or affirmation of, their knowledge of clinical medicine. Participants should be able to evaluate the appropriateness of the clinical information as it applies to the provision of patient care.

PARTICIPANTS

This program is designed for physicians who are involved in providing patient care and who wish to advance their current knowledge of clinical medicine.

CREDITS

The American Academy of Neurology designates that participants will receive 1.5 AMA PRA Category 1 CME credits if both CME courses for the issue are completed.

The American Academy of Neurology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians.

DISCLOSURES

Steven Lewis, MD receives a stipend in his editorial capacity for Neurology and as an Associate Editor for Continuum: Lifelong Learning in Neurology; has received royalties for the books Field Guide to the Neurologic Examination and Neurology for the Non-Neurologist; and anticipates receiving royalties for the book Neurologic Disorders due to Systemic Disease. James WM Owens Jr. MD, PhD receives royalties from UpToDate, Waltham, MA; grant support from NIH (PI, K08NS054882); and a stipend in his editorial capacity for Neurology.

COMMERCIAL SUPPORT

This CME program receives no commercial support.

Content failed to load, please try again later.

ACCME